Hemorrhoid Market Opportunity

CRH Medical Corporation was established as a medical services company specializing in the treatment of hemorrhoids utilizing the Company owned CRH O’Regan System. This single-use, 100% disposable technology is minimally invasive and has been found to be 99.1% effective and 99.8% pain free in the treatment of hemorrhoids grade I – IV and allows most patients to return work the same day following treatment. The CRH O'Regan System is available to patients nationally through partner gastroenterologists and surgeons who have been trained to perform the procedure.

Market Overview

Though few people like to talk about them, hemorrhoids are extremely common. By age 50, about half of the US population will have experienced this potentially painful condition. Common causes include constipation, pregnancy, childbirth, obesity, heavy lifting, sitting for long periods and diarrhea.

According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the prevalence of hemorrhoids in the United States is 10.4 million people, with approximately 1 million new cases diagnosed every year. Yet only 3.5 million of the 10.4 million people with the condition seek medical treatment, making it a dramatically under-treated problem.

Despite the number of patients who suffer in silence, millions of hemorrhoid banding procedures are performed each year, making it the most common procedure performed worldwide. As the baby boomer population ages, and awareness of nonsurgical treatment options grows, it is expected that the number of banding procedures will rise.

That’s a good thing for a number of reasons. For one, more patients will enjoy a permanent cessation of symptoms that may have plagued them for years. Additionally, proper treatment of hemorrhoids allows for accurate screening for colorectal cancer. That’s because it removes hemorrhoids as a cause of blood in the stool.

Business Opportunity

We are currently working with leading Gastroenterology and Surgical Practices to achieve the fastest possible adoption of the CRH Technology by a broad segment of the medical community. This initiative is increasing the number of physicians using our products and is helping to rapidly capture market share, build brand awareness and create value.

We provide physicians with the opportunity to utilize our hemorrhoid banding technology, treatment protocols, training, marketing and operational experience as a complete “turn key” package. This allows practices to increase revenues, expand the continuum of care and provide a fast, painless and permanent solution for patients.  Approximately 14 million colonoscopies are performed each year, with an estimated 15 - 20% of those identifying a diagnosis of symptomatic hemorrhoids. The market indicates that most of these potential patients are going untreated.